Tenofovir (Viread): Research
 ARV Pipeline: Dolutegravir, TAF (GS-7340), MK-1439 and Cenicriviroc (March/April 2013)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
On TheBodyPRO.com
- Tenofovir Use in Children (March/April 2013)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
On TheBodyPRO.com
- New Tenofovir Prodrug (TAF): One Study Whose Impact Will Last Well Beyond CROI 2013 (March 14, 2013)
In The 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013), from TheBodyPRO.com
- New Pro-Drug Tenofovir Alafenamide Appears Equally Effective but Better Tolerated (March 7, 2013)
From aidsmap.com
 New Tenofovir Prodrug Shows Potency, Plus Better Kidney and Bone Safety Than Current Formulation (March 7, 2013)
In The 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013), from TheBodyPRO.com
- In HIV, Old Drug Is New Again (March 6, 2013)
From MedPage Today
- New Tenofovir Alafenamide Looks Easier on Kidneys (Video) (March 6, 2013)
From HIVandHepatitis.com
- New Tenofovir Prodrug Virologically Equivalent to TDF -- and Easier on Kidneys and Bone (March 5, 2013)
From National AIDS Treatment Advocacy Project
 The Hot List: Top 10 HIV Conference Articles of 2012 on TheBodyPRO.com (December 18, 2012)
From TheBodyPRO.com
 Building a Better Tenofovir: Oral Prodrug GS-7340 Outperforms "Old" Tenofovir, Research Finds (October 26, 2012)
In The 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2012) , from TheBodyPRO.com
- Switching to Tenofovir in ART Regimen Suppresses Hepatitis B in HIV/HBV Coinfected (September 14, 2012)
From HIVandHepatitis.com
- Proteinuria as a Potential Early Marker of Tenofovir-Related Renal Toxicity (July/August 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
On TheBodyPRO.com
- Switching to Rilpivirine/Tenofovir/FTC Fixed-Dose Combination From Boosted-PI Regimen: SPIRIT Study Draws the Line at 24 Weeks (July/August 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
On TheBodyPRO.com
- Tenofovir Prophylaxis for Neonates (July/August 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
On TheBodyPRO.com
- Associations Between Tenofovir Use and Renal Complications in VA Cohort (May/June 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
On TheBodyPRO.com
 Anti-HIV Drug Use During Pregnancy Does Not Affect Infant Size, Birth Weight (May 1, 2012)
NIH study indicates drug safe during pregnancy, but infants smaller at first birthday.
From U.S. National Institutes of Health
On TheBodyPRO.com
- EASL: Entecavir Plus Tenofovir for Hepatitis B Patients With Prior Treatment Failure (April 20, 2012)
From HIVandHepatitis.com
- Switching to Tenofovir Increases Bone Turnover, Raltegravir Can Improve Bone Density (April 10, 2012)
From HIVandHepatitis.com
- Tenofovir Prodrug: 10-Day Monotherapy Study Sets Dose at 25 mg for Easier Coformulation (March/April 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
On TheBodyPRO.com
 CROI 2012: New Version of Tenofovir May Be Safer and More Suppressive (March 26, 2012)
From Project Inform
On TheBodyPRO.com
- The Path to a Cure (January/February 2012)
The pathway to an HIV cure and other treatments in the pipeline.
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
|
Advertisement
|
Email
Glossary
